Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-03-01
2011-03-01
Pryor, Alton N (Department: 1616)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S315000, C514S376000, C514S513000, C514S546000, C514S643000
Reexamination Certificate
active
07897598
ABSTRACT:
Analogs that inhibit the transport of anandamide across cell membranes. The inhibitors are amide and ester analogs of anandamide having a tail portion X that is a fatty acid chain remnant, a central portion Y that is an amide or ester radical and a head portion Z that is selected from a variety of groups including hydrogen, alkyl, hydroxy alkyl, aryl, hydroxy aryl, heterocyclic and hydroxy heterocyclic radicals. The disclosed analogs have potential pharmaceutical uses as drugs for treating a variety of diseases and afflictions, including cardiovascular diseases and blood pressure disorders.
REFERENCES:
patent: 3041343 (1962-06-01), Jucker et al.
patent: 3465024 (1969-09-01), Brownstein et al.
patent: 3573327 (1971-03-01), Miyano
patent: 3577458 (1971-05-01), Brownstein et al.
patent: 3656906 (1972-04-01), Bullock
patent: 3838131 (1974-09-01), Gauthier
patent: 3886184 (1975-05-01), Matsumoto et al.
patent: 3897306 (1975-07-01), Vidic
patent: 3915996 (1975-10-01), Wright
patent: 3928598 (1975-12-01), Archer
patent: 3944673 (1976-03-01), Archer
patent: 3946029 (1976-03-01), Descamps et al.
patent: 3953603 (1976-04-01), Archer
patent: 4036857 (1977-07-01), Razdan et al.
patent: 4054582 (1977-10-01), Blanchard et al.
patent: 4087545 (1978-05-01), Archer et al.
patent: 4087546 (1978-05-01), Archer et al.
patent: 4087547 (1978-05-01), Archer et al.
patent: 4088777 (1978-05-01), Archer et al.
patent: 4102902 (1978-07-01), Archer et al.
patent: 4152450 (1979-05-01), Day et al.
patent: 4171315 (1979-10-01), Ryan et al.
patent: 4176233 (1979-11-01), Archer et al.
patent: 4179517 (1979-12-01), Mechoulam
patent: 4188495 (1980-02-01), Althuis et al.
patent: 4208351 (1980-06-01), Archer et al.
patent: 4278603 (1981-07-01), Thakkar et al.
patent: 4282248 (1981-08-01), Mechoulam et al.
patent: 4382943 (1983-05-01), Winter et al.
patent: 4395560 (1983-07-01), Ryan
patent: 4497827 (1985-02-01), Nelson
patent: 4550214 (1985-10-01), Mehta
patent: 4758597 (1988-07-01), Martin et al.
patent: 4812457 (1989-03-01), Narumiya
patent: 4876276 (1989-10-01), Mechoulam
patent: 4885295 (1989-12-01), Bell et al.
patent: 5053548 (1991-10-01), Tanaka et al.
patent: 5068234 (1991-11-01), D'Ambra et al.
patent: 5147876 (1992-09-01), Mizuchi et al.
patent: 5223510 (1993-06-01), Gubin et al.
patent: 5284867 (1994-02-01), Kloog
patent: 5324737 (1994-06-01), D'Ambra et al.
patent: 5434295 (1995-07-01), Mechoulam et al.
patent: 5440052 (1995-08-01), Makriyannis et al.
patent: 5462960 (1995-10-01), Barth et al.
patent: 5489580 (1996-02-01), Makriyannis et al.
patent: 5521215 (1996-05-01), Mechoulam
patent: 5532237 (1996-07-01), Gallant et al.
patent: 5538993 (1996-07-01), Mechoulam
patent: 5576436 (1996-11-01), McCabe et al.
patent: 5605906 (1997-02-01), Lau
patent: 5607933 (1997-03-01), D'Ambra et al.
patent: 5618955 (1997-04-01), Mechoulam et al.
patent: 5624941 (1997-04-01), Barth et al.
patent: 5631297 (1997-05-01), Pate et al.
patent: 5635530 (1997-06-01), Mechoulam
patent: 5688825 (1997-11-01), Makriyannis et al.
patent: 5744459 (1998-04-01), Makriyannis et al.
patent: 5747524 (1998-05-01), Cullinan et al.
patent: 5804601 (1998-09-01), Kato et al.
patent: 5817651 (1998-10-01), D'Ambra et al.
patent: 5872148 (1999-02-01), Makriyannis et al.
patent: 5874459 (1999-02-01), Makriyannis et al.
patent: 5925628 (1999-07-01), Lee et al.
patent: 5925768 (1999-07-01), Barth et al.
patent: 5932610 (1999-08-01), Shohami et al.
patent: 5939429 (1999-08-01), Kunos et al.
patent: 5948777 (1999-09-01), Bender et al.
patent: 6013648 (2000-01-01), Rinaldi et al.
patent: 6028084 (2000-02-01), Barth et al.
patent: 6096740 (2000-08-01), Mechoulam
patent: 6127399 (2000-10-01), Yuan
patent: 6166066 (2000-12-01), Makriyannis et al.
patent: 6284788 (2001-09-01), Mittendorf et al.
patent: 6391909 (2002-05-01), Makriyannis et al.
patent: 6579900 (2003-06-01), Makriyannis et al.
patent: 7161016 (2007-01-01), Makriyannis et al.
patent: 2002/0119972 (2002-08-01), Leftheris et al.
patent: 2002/0173528 (2002-11-01), Fride et al.
patent: 2003/0120094 (2003-06-01), Makriyannis et al.
patent: 0276732 (1988-08-01), None
patent: 0444451 (1991-09-01), None
patent: 0471609 (1993-06-01), None
patent: 0576357 (1993-12-01), None
patent: 0737671 (1996-10-01), None
patent: 0860168 (2001-09-01), None
patent: 2240003 (1975-05-01), None
patent: 2735774 (2000-01-01), None
patent: 2027021 (1980-02-01), None
patent: 1995-113228 (1999-09-01), None
patent: 57098228 (1982-06-01), None
patent: 2304080 (1990-12-01), None
patent: WO 94/12466 (1994-06-01), None
patent: WO 97/00860 (1997-01-01), None
patent: WO 97/21682 (1997-06-01), None
patent: WO 97/45407 (1997-12-01), None
patent: WO 99/57106 (1999-11-01), None
patent: WO 99/57107 (1999-11-01), None
patent: WO 00/32200 (2000-06-01), None
patent: WO 01/28329 (2001-04-01), None
patent: WO 01/28497 (2001-04-01), None
patent: WO 01/28498 (2001-04-01), None
patent: WO 01/28557 (2001-04-01), None
patent: WO 01/29007 (2001-04-01), None
patent: WO 01/32169 (2001-05-01), None
patent: WO 01/58869 (2001-08-01), None
patent: WO 02/058636 (2002-08-01), None
patent: WO 02/060447 (2002-08-01), None
Khanolkar et al, Head Group Analogs of Arachidonylethanolamide, 1996, J. Med. Chem., vol. 39 No. 22, pp. 4515-4519.
DiMarzo et al, Interactions between synthetic vanilloids and the endogenous cannabinoid system, FEBS Letters 1998, 436(3), 449-54.
Beltramo et al, Anandamide transprot inhibition by the vanilloid agonist olvanil, European J. of Pharmocology, 1999, 364 (1), 75-8.
Melck et al, Unsaturated Long-Chain N-Acyl-vanillyl-amides, Biochemical and Biophysical Res. Commun., 1999, 262 (1), 275-284.
Beltramo et al, Functional role of high-affinity anandamide transport, as revealed by selective inhibition, Science, 277, 1997, 1094-1097.
Calignano et al, Potentiation of anandamide hypotension by the transport inhibitor, AM404, European J. of Pharmacology, 1997, vol. 337 No. 1, R1-R2 (abs).
Abadji et al (R-Methanandamide: A Chiral Novel Anandamide Possessing Higher Potency and Metabolic Stability, J. of Medicinal Chem., 1994, vol. 37, No. 12, pp. 1889-1893).
Calignano et al (Potentiation of anandamide hypotension by the transport inhibitor, AM404, European J. of Pharm, 1997, vol. 337, pp. R1-R2.
Beltramo et al. (Anandamide transport inhibition by the vanilloid agonist olvanil, European Journal of Pharmacology 364, 1999, 75-78).
Street et al. (Slow- and Tight-Binding Inhibitors of the 85-kDa Human Phospholipase A2, Biochemistry, 32, 1993, 5935-40).
Machoulam et al, Identification of an endogenous 2-monoglyceride, present in canine cut, that binds to cannabinoid receptors, Biochemical Pharmacology, vol. 50 (1), pp. 83-90, 1995.
“Roles of Mu, Delta and Kappa Opioid Receptors in Spinal and Supraspinal Mediation of Gastrointestinal Transit Effects and Hot-Plate Analgesia in the Mouse,” F. Porreca, H. I. Mosberg, R. Hurst, V.J. Hruby and T.F. Burks;J. Pharmacol. Exp. Ther., 230: 341-8 (1994).
“Anandamide, an Endogenous Cannabinoid, Inhibits Calcium Currents as a Partial Agonist in N18 Neuroblastoma Cells”, K. Mackie, W.A. Devane and B. Hille,Mol. Pharmacol., 44:498-503 (1993).
Abstract from “Anandamide, a brain endogenous compound, interacts specifically with cannabinoid receptors and inhibits adenylate cyclase”, Z. Vogel, J. Barg, R. Levy, D. Saya, E. Heldman, R. Mechoulam;J. Neurochem., 61(1):352-5 (1993).
U.S. Appl. No. 10/110,865, filed Oct. 18, 2000, Makriyannis et al.
U.S. Appl. No. 10/110,830, filed Oct. 18, 2000, Makriyannis et al.
U.S. Appl. No. 10/110,812, filed Oct. 18, 2000, Makriyannis et al.
U.S. Appl. No. 10/110,862, filed Oct. 18, 2000, Makriyannis et al.
U.S. Appl. No. 10/111,059, filed Oct. 18, 2000, Makriyannis et al.
Alo, B.I., Kandil, A.; Patil, P. A.; Sharp, M. J.; Siddiqui, M. A.; and Snieckus, V. Sequential Directed Ortho Metalation-Boronic Acid Cross-Coupling Reactions. A general Regiospecific Route to Oxygenerated Dibenzo[b,d]pyran-6-ones Related to Ellagic Acid, J. Org. Chem. 1991, 56, 3763-3768.
*** Archer et al; “cannabinoids, synthesis approaches to 9-ketocannabinoids
Lin Sonyuan
Makriyannis Alexandros
Piomelli Daniele
Alix Yale & Ristas, LLP
Pryor Alton N
LandOfFree
Inhibitors of the anandamide transporter does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibitors of the anandamide transporter, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibitors of the anandamide transporter will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2639085